Experience of lipoprotein (a) dosage in 184 moroccan subjects;Experience du dosage de la lipoproteine (a) dans une population marocaine de 184 sujets

Archives des Maladies du Coeur et des Vaisseaux

Volumn 90, Issue 10, 1997, Pages 1371-1376

  Fellat, S ^a,b   Lahfidi, K ^a,b   Srairi J E ^a,b   El Haitem N ^a,b   Mesbahi, R ^a,b   Ghanam, R ^a,b   Benomar, M ^a,b  

^a Ligue Nationale de Lutte Contre les Maladies Cardiovasculaires   (Morocco)

^b IBN SINA HOSPITAL   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BIOLOGICAL MARKER; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; COLORIMETRY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DISCRIMINANT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; BLOOD; COMPARATIVE STUDY; MIDDLE AGED; MOROCCO; PREDICTION AND FORECASTING; PREVALENCE;

ADULT; AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MOROCCO; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; TRIGLYCERIDES;

EID: 0030664245     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Zionchek TF, Powell IM, Rice GC, Eaton DL. Lawn RM. Interaction of recombinant qpolipoprotein (a) and the lipoprotein (a) with macrophages. J Clin Invest 1991 ; 87 : 767-71.
2. Hearn JA, De Maio SJ, Roybin GS, Hammarstrom M, Sgoutas D. Predictive value of lipoprotein (a) and other serum lipoproteins in the angiographic diagnosis of coronary artery disease. Am J Cardiol l990 ; 66 : 1176-80.
3. Hoff HF, Beck GJ, Skibinski CI et al. Serum Lp(a) Jevej as a predictor of vein graft stenosis after coronary artery bypass'surgery in patients. Circulation 1988 ; 77 : 1238-44.
4. Dohlen GH. Lipoprotein (a), atherosclerosis and thrombosis. Prog Lipid Res 1991 ; 30 : 189-94.
5. Gushing GL, Gaubaty JW, Nava ML et al. Quantitation and localization of apolipoproteins (a) and B in coronary artery bypass vein grafts resected at re-operation. Atherosclerosis 1989; 9: 593-603.
6. Hearn JA, Donohue BC, Ba'albaki H et al. Usefulness of serum Lp[a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1992 ; 69 : 736-9.
7. Sandholzer C, Saha N, Kark JD et al. Apo (a) isoforms predict risk for coronary heart disease. A study in six populations. Arteriosclerosis Thromb 1992 ; 12 : 1214-26.
8. Klausen IC, Beisiegel U, Menzel HJ, Rosseneu M, Nicaud V, Faergeman O. Apo (a) phenotypes and Lp (a) concentrations in offspring of men with and without myocardial infarction. The EARS study. Arteriosclerosis Thromb Vase Biol 1995 ; 15 : 1001-8.
9. Rifoi N, Heiss G, Doetsch K. Lipoprotein (a) at birth, in blacks and whites. Atherosclerosis 1992 ; 92 : 123-9.
10. Lobo RA, Noteloyitz M, Bernstein l, Kahn FY, Ross RK. Lp(a) lipoprotein ; relationship to cardiovascular disease risk factors, exercise, and estrogen. Am J Obstet Gynecol 1992 ; 166 : 1182-90.
11. Jenner JL, Or do va s JM, Lamon-Fava S et al. Effect of aae, sex and menopausal status on plasma lipoprotein (a) levels : the Framingham offspring study. Circulation 1993 ; 87 : 1135-41.
12. Heinrich J, Sandkamp M, Kokott R, Schulte H, Assman G. Relationship of lipoprotein (a) to variables of coagulation and fibrinolysis in a healthy population. Clin Chem 1991 ; 37: 1950-4.
13. Haffner SM, Turtle KR, Rainwater DL. Decrease of lipoprotein (a) with improved glycémie control in IDDM subjects. Diabetes Care 1991 ; 14 : 302-7.
14. Nakata H, Horita K, Eto M. Alteration of lipoprotein (a) concentration with glycoemic control in non insulin-dependent diabetic subjects without diabetic complications. Metabolism 1993 ; 42 : 1323-6.
15. Schlienger JL, Grunenberger F. La lipoprotéine Lp (a) : nouveau facteur de risque cardiovasculaire. Concours Med 1992 : 114-9.
16. Schaefer EJ, Lamon-Fava S, Jenner JL et al. Lipoprotein (al levels and risk on coronary heart disease in men. J Am Med Assoc 1994; 271 : 999-1003.